文献速递冠心病外科

等待心肌血运重建期间的不良事件:系统综述与荟萃分析

Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

该系统综述与荟萃分析检索PubMed并纳入22项观察性研究、共66 410例等待CABG或PCI的患者,估算等待期间死亡、非致死性心肌梗死和急诊血运重建的发生率。等待CABG期间每1000患者周死亡率1.1,非致死性心肌梗死1.0,急诊血运重建1.8;等待PCI期间相应发生率较低但证据来自少数旧研究。半紧急状态患者死亡风险至少为择期患者的2.8倍。

要点

  • 等待CABG期间每1000患者周死亡1.1、非致死性心肌梗死1.0、急诊血运重建1.8。
  • 等待PCI期间每1000患者周死亡0.1、非致死性心肌梗死0.4、急诊血运重建0.7。
  • 半紧急状态患者等待死亡风险至少为择期患者的2.8倍。

核心结论

  • 等待心肌血运重建期间死亡、非致死性心肌梗死和急诊血运重建不常见,但在特定患者中更高。
  • 尚未制定等待时间相关治疗建议的国家应考虑引入最长等待时间以限制不良事件,尤其是等待CABG时。

研究设计与样本

  • 系统综述与荟萃分析,2015年1月19日检索PubMed,纳入22项英文原创观察性研究,共66 410例患者和607 675患者周等待时间。
  • 以每1000患者周发生率计算死亡、非致死性心肌梗死和急诊血运重建,并采用随机效应模型合并。

主要发现

  • 等待CABG期间每1000患者周死亡率为1.1(95%CI 0.9-1.3),非致死性心肌梗死为1.0(95%CI 0.6-1.6),急诊血运重建为1.8(95%CI 0.8-4.1)。
  • 等待PCI期间每1000患者周死亡率为0.1(95%CI 0.0-0.4),非致死性心肌梗死为0.4(95%CI 0.1-1.2),急诊血运重建为0.7(95%CI 0.4-1.4),但仅基于少数旧研究。
  • 亚组分析结果一致,敏感性分析事件率相当且异质性低。
  • 半紧急状态患者等待期间死亡风险至少为择期血运重建患者的2.8倍。
  • 个体研究识别心绞痛严重程度和左心室功能障碍为等待CABG期间死亡的最重要预测因素。

关键数值与推荐

  • 血运重建紧迫性较高主要基于血管造影复杂性、心绞痛严重程度、左心室功能障碍和负荷试验症状。
  • 等待CABG期间每1000患者周死亡1.1、非致死性心肌梗死1.0、急诊血运重建1.8。
  • 等待PCI期间每1000患者周死亡0.1、非致死性心肌梗死0.4、急诊血运重建0.7。
  • 半紧急状态患者死亡风险比至少为2.8(相对择期血运重建患者)。

临床怎么用

  • 对等待CABG的患者应评估血管造影复杂性、心绞痛严重程度、左心室功能障碍和负荷试验症状以识别高风险者。
  • 半紧急状态患者等待期间死亡风险较高,应优先安排血运重建。
  • 尚未制定等待时间建议的国家可考虑引入最长等待时间以减少不良事件,尤其是等待CABG时。

局限性

  • 等待PCI期间的事件率仅基于少数旧研究。
  • 纳入研究为观察性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of the current study was to estimate adverse event rates while awaiting myocardial revascularization and review criteria for prioritizing patients. METHODS: A PubMed search was performed on 19 January 2015, to identify English-language, original, observational studies reporting adverse events while awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). Rates of death, non-fatal myocardial infarction (MI) and emergency revascularization were calculated as occurrence rates per 1000 patient-weeks and pooled using random-effects models. RESULTS: The search yielded 1323 articles, of which 22 were included with 66 410 patients and 607 675 patient-weeks on the wait list. When awaiting CABG, rates per 1000 patient-weeks were 1.1 [95% confidence interval 0.9-1.3] for death, 1.0 [0.6-1.6] for non-fatal MI and 1.8 [0.8-4.1] for emergency revascularization. Subgroup analyses demonstrated consistent outcomes, and sensitivity analyses demonstrated comparable event rates with low heterogeneity. Higher urgency of revascularization was based primarily on angiographic complexity, angina severity, left ventricular dysfunction and symptoms on stress testing, and such patients with a semi-urgent status had a higher risk of death than patients awaiting elective revascularization (risk ratio at least 2.8). Individual studies identified angina severity and left ventricular dysfunction as most important predictors of death when awaiting CABG. Adverse rates per 1000 patient-weeks for patients awaiting PCI were 0.1 [95% confidence interval 0.0-0.4] for death, 0.4 [0.1-1.2] for non-fatal MI and 0.7 [0.4-1.4] for emergency revascularization but were based on only a few old studies. CONCLUSIONS: Rates of death, non-fatal MI and emergency revascularization when awaiting myocardial revascularization are infrequent but higher in specific patients. Countries that not yet have treatment recommendations related to waiting times should consider introducing a maximum to limit adverse events, particularly when awaiting CABG.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Head SJ, da Costa BR, Beumer B, et al. Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017. PMID: 28472484. doi:10.1093/ejcts/ezx115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。